9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatric disorders, such as schizophrenia and bipolar disorder. In this context, the current study explored the relationship between behavioral and psychological symptoms of dementia (BPSD) and clinical competence, especially the capacity to consent to treatment, in Alzheimer’s disease (AD). Seventy-one patients with mild to moderate AD participated, completing assessments for capacity to consent to treatment, general cognition and neuropsychiatric disturbances. For each neuropsychiatric symptom, patients with and without the particular disturbance were compared on the different subscales of the MacArthur Competence Tool for Treatment (MacCAT-T; Understanding, Appreciation, Reasoning and Expression). The results showed that patients presenting delusions, as well as apathetic patients, had a lower ability to express a clear treatment choice compared to patients without these symptoms. By contrast, patients with dysphoria/depression had higher scores on this variable. Additionally, AD patients with euphoria had more difficulties discussing consequences of treatment alternatives compared to patients without this disturbance. None of the differences were confounded by global cognition. There were no between-group differences in clinical decision-making for patients with hallucinations, agitation/aggression, anxiety, irritability, disinhibition and aberrant motor behavior. These findings highlight the importance of taking BPSD into account when assessing decision-making capacity, especially clinical competence, in AD. Furthermore, reducing BPSD may lead to better clinical competence in patients with AD, as well as to improvements in patients and caregivers’ quality of life.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders.

          There is wide acknowledgement that apathy is an important behavioural syndrome in Alzheimer's disease and in various neuropsychiatric disorders. In light of recent research and the renewed interest in the correlates and impacts of apathy, and in its treatments, it is important to develop criteria for apathy that will be widely accepted, have clear operational steps, and that will be easily applied in practice and research settings. Meeting these needs is the focus of the task force work reported here. The task force includes members of the Association Française de Psychiatrie Biologique, the European Psychiatric Association, the European Alzheimer's Disease Consortium and experts from Europe, Australia and North America. An advanced draft was discussed at the consensus meeting (during the EPA conference in April 7th 2008) and a final agreement reached concerning operational definitions and hierarchy of the criteria. Apathy is defined as a disorder of motivation that persists over time and should meet the following requirements. Firstly, the core feature of apathy, diminished motivation, must be present for at least four weeks; secondly two of the three dimensions of apathy (reduced goal-directed behaviour, goal-directed cognitive activity, and emotions) must also be present; thirdly there should be identifiable functional impairments attributable to the apathy. Finally, exclusion criteria are specified to exclude symptoms and states that mimic apathy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            [The Mini-Mental State Examination in a general population: impact of educational status].

            To assess the influence of age and education on cognitive performance in our population, 530 adults were interviewed using the MMSE (Mini-Mental Status Examination). Education level, classified as illiterate, elementary and middle ( 8 years), was a significant predictor of performance (p or = 65 years). The reference cut-off values were taken from the fifth percent lowest score for each group: illiterate, 13; elementary and middle, 18; and high, 26. When compared to 94 patients with cognitive impairment, our cut-off values achieved high sensitivity (82.4% for illiterates; 75.6% for elementary and middle; 80% for high) and specificity (97.5% for illiterate; 96.6% for elementary and middle; 95.6% for high educational level). Education-specific reference values for the MMSE are necessary in interpreting individual test results in populations of low educational level, in order to reduce the false positive results.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions.

              The feasibility, reliability, and validity of a new instrument, the MacArthur Competence Assessment Tool-Treatment (MacCAT-T), which was developed for use by clinicians, was tested. The instrument assesses patients' competence to make treatment decisions by examining their capacities in four areas--understanding information relevant to their condition and the recommended treatment, reasoning about the potential risks and benefits of their choices, appreciating the nature of their situation and the consequences of their choices, and expressing a choice. The MacCAT-T and instruments to measure symptom severity were administered to 40 patients recently hospitalized with schizophrenia or schizoaffective disorder and 40 matched subjects in the community without mental illness. A high degree of ease of use and interrater reliability was found for the MacCAT-T. Overall, the hospitalized patients performed significantly more poorly than the community subjects on understanding and reasoning, although many patients performed as well as community subjects. Poor performance was related to higher levels of some psychiatric symptoms, such as conceptual disorganization, hallucinations, and disorientation. The MacCAT-T offers a flexible yet structured method with which caregivers can assess, rate, and report patients' abilities relevant for evaluating competence to consent to treatment.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Aging Neurosci
                Front Aging Neurosci
                Front. Aging Neurosci.
                Frontiers in Aging Neuroscience
                Frontiers Media S.A.
                1663-4365
                16 June 2017
                2017
                : 9
                : 182
                Affiliations
                [1] 1Department of Psychology, Pontifícia Universidade Católica – Rio (PUC-Rio) Rio de Janeiro, Brazil
                [2] 2Department of Medical Psychology, VU University Medical Center Amsterdam, Netherlands
                [3] 3Diabetes Center/Department of Internal Medicine, VU University Medical Center Amsterdam, Netherlands
                [4] 4Institute of Psychiatry—Center for Alzheimer’s Disease, Federal University of Rio de Janeiro (UFRJ) Rio de Janeiro, Brazil
                [5] 5Post Graduation Program on Translational Biomedicine, Universidade do Grande Rio (Unigranrio) Caxias, Brazil
                [6] 6Institute of Psychiatry, Psychology & Neuroscience, King’s College London London, United Kingdom
                Author notes

                Edited by: Agustin Ibanez, Institute of Cognitive and Translational Neuroscience (INCYT), Argentina

                Reviewed by: Olivier Piguet, University of Sydney, Australia; Sandra Baez, Institute of Cognitive and Translational Neuroscience (INCYT), Argentina

                *Correspondence: Elodie Bertrand elodie.bertrand1@ 123456gmail.com
                Article
                10.3389/fnagi.2017.00182
                5472652
                87ff662a-d785-4362-a120-c9bbedc743e7
                Copyright © 2017 Bertrand, van Duinkerken, Landeira-Fernandez, Dourado, Santos, Laks and Mograbi.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 26 November 2016
                : 24 May 2017
                Page count
                Figures: 1, Tables: 3, Equations: 0, References: 60, Pages: 8, Words: 5726
                Funding
                Funded by: Conselho Nacional de Desenvolvimento Cientà­fico e Tecnológico 10.13039/501100003593
                Categories
                Neuroscience
                Original Research

                Neurosciences
                bpsd,clinical capacity,decision making,consent to treatment,dementia,alzheimer’s disease

                Comments

                Comment on this article